Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
68
Frequently Asked Questions
What is Market Cap of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B market cap is $3.25B.
What is the 52-week high for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B 52 week high is $169.49 as of September 16, 2025.
What is the 52-week low for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B 52 week low is $93.58 as of September 16, 2025.
What is Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price today?
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price today is $165.52.
What was Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price yesterday?
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price yesterday was $165.75.
What is the PE ratio of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B’s P/E ratio is -41.47.
What is the Price-to-Book ratio of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B P/B ratio is 3.8832.
What is the 50-day moving average of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B 50-day moving average is $145.15.
How many employess does Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B has?
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B has 68 employees.
